Dermatitis, Eczematous Recruiting Phase 4 Trials for Crisaborole (DB05219)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03832010Steroid-reducing Effects of CrisaboroleTreatment